Clinical trialNCT01186458TerminatedPhase 2Interventional

Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

SponsorHoosier Cancer Research NetworkEnrollment4Lymphoma, Non-Hodgkin

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the effectiveness of fludarabine, Velcade, and rituximab treatment regimen in patients with relapsed or refractory follicular non-Hodgkin lymphoma.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Shivani Srivastava, M.D.
Hoosier Cancer Research Network
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Cancer Care Center of Southern Indiana
Bloomington, Indiana, United States
Fort Wayne Oncology & Hematology, Inc
Fort Wayne, Indiana, United States
Community Regional Cancer Center
Indianapolis, Indiana, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Arnett Cancer Care
Lafayette, Indiana, United States
Virtua Health Cancer Program
Mount Holly, New Jersey, United States
South Jersey Health Care
Vineland, New Jersey, United States
University of Rochester Medical Center
Rochester, New York, United States
Case Comprehensive Cancer Center - University Hospitals Case Medical Center
Cleveland, Ohio, United States
Seidman Cancer Center
Cleveland, Ohio, United States
Reading Hospital Regional Cancer Center
West Reading, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fludarabine →Rituximab →Velcade

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2010
Primary completion: 31 Oct 2013
Completion: 31 Oct 2013
Last update posted: 24 Oct 2016
Registered enrollment: 4
Registry id: NCT01186458

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.